Mercaptopurin 50 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

mercaptopurin 50 mg comprimate

belmedpreparatî rup - mercaptopurinum - comprimate - 50 mg

Methylprednisolone 1 g pulbere pentru soluţie injectabilă/perfuzabilă Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

methylprednisolone 1 g pulbere pentru soluţie injectabilă/perfuzabilă

swiss parenterals pvt.ltd. - alprazolamum - pulbere pentru soluţie injectabilă/perfuzabilă - 1 g

PURI - NETHOL 50 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

puri - nethol 50 mg

excella gmbh & co. kg - germania - mercaptopurinum - compr. - 50mg - antimetaboliti analogi ai bazelor purinice

CO-NEBILET 5 mg/12,5mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

co-nebilet 5 mg/12,5mg

berlin - chemie ag - germania - combinatii (nebivololum+hydrochlorothiazidum) - compr. film. - 5mg/12,5mg - medicamente betablocante si tiazide medicamente betablocante selective si tiazide

CO-NEBILET 5 mg/25mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

co-nebilet 5 mg/25mg

berlin - chemie ag - germania - combinatii (nebivololum+hydrochlorothiazidum) - compr. film. - 5mg/25mg - medicamente betablocante si tiazide medicamente betablocante selective si tiazide

CO-PERINEVA 4 mg/1,25 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

co-perineva 4 mg/1,25 mg

krka, d.d., novo mesto - slovenia - combinatii (perindoprilum+indapamidum) - compr. - 4mg/1,25mg - combinatii de inhibitori ai e.c.a. inhibitori ai e.c.a. si diuretice - combinati

IMURAN 50 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

imuran 50 mg

excella gmbh & co. kg - germania - azathioprinum - compr. film. - 50mg - imunosupresoare alte imunosupresoare

Jayempi Uniunea Europeană - română - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - respingerea grefei - imunosupresoare - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Nebilet Plus 5 mg/12,5 mg comprimate filmate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

nebilet plus 5 mg/12,5 mg comprimate filmate

menarini international operations luxembourg sa - nebivololum + hydrochlorothiazidum - comprimate filmate - 5 mg/12,5 mg

Fasturtec Uniunea Europeană - română - EMA (European Medicines Agency)

fasturtec

sanofi winthrop industrie - rasburicaza - hiperuricemia - toate celelalte produse terapeutice - tratament şi profilaxie a hyperuricaemia acute, în scopul de a preveni insuficienţa renală acută, la adulţi, copii şi adolescenţi (cu vârste cuprinse între 0-17 ani) cu tumori maligne hematologice cu o tumoare mare povară şi risc de liză tumorală rapidă sau contractie la iniţierea de chimioterapie.